前庭动和初级保健预防和康复 - - 一项可行性研究
Caroline M Elnegaard1,2,3, Maria K Pedersen4, Ann-Dorthe O Zwisler5,6,7
1Department of Cardiology, Odense University Hospital, Odense, Denmark. caroline.matilde.elnegaard@rsyd.dk.
Pilot and feasibility studies
|November 27, 2025
概括
对心房 (AF) 的初级保健干预改善了生活质量,减少了焦虑和抑郁. 这一复杂的计划,包括教育和炼,被证明是可行的,对AF患者来说是非常可接受的.
科学领域:
- 心脏病学 心脏病学
- 主要护理医学 医疗保健
- 健康心理学 心理健康心理学
背景情况:
- 在全球范围内,心房动 (AF) 的患病率正在上升,影响生活质量,增加医疗负担.
- 目前的管理策略往往缺乏整合到初级保健设置.
- 现有的干预措施,如教育和运动显示出希望,但需要进一步的证据,复杂的,多元件的程序.
研究的目的:
- 评估一项全面的AF预防和康复计划在初级保健中的可行性.
- 探索患者的经验,接受度和有关干预的需求.
- 评估与健康相关的生活质量 (HRQoL),焦虑和抑郁症的变化,以及收集患者报告结果措施 (PROM) 的可行性.
主要方法:
- 一项单臂可行性研究涉及50名来自大学医院AF诊所转诊的AF参与者.
- 这是一个复杂的干预措施,包括患者教育,体育炼,药用,心理社会支持和风险因素管理.
- 混合方法采用PROM收集HRQoL,焦虑和抑郁症的数据,以及重点小组采访和现场笔记.
主要成果:
- 高完成率 (86%) 和复杂干预在初级保健环境中的可行性.
- 从基线到随访期间,HRQoL显著改善,焦虑和抑郁症状减少.
- 定性数据强调了医疗保健专业人员和同行支持,增强知识和AF管理应对工具的价值.
结论:
- 在初级保健环境中,全面的AF干预是可行的和可以接受的.
- 该干预措施在改善患者结果和管理AF方面表现出潜在的有效性.
- 需要进一步的大规模随机对照试验来证实这些发现.
相关概念视频
01:25Dysrhythmias VI: Management of Dysrhythmias
418
Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
418
01:21Rheumatic Heart Disease III: Medical Management
268
Rheumatic heart disease (RHD) management can be divided into two main strategies: prevention and long-term management.Primary PreventionPrimary prevention focuses on timely diagnosis and management of group A streptococcal pharyngitis to prevent acute rheumatic fever. The most widely used antibiotic for treating this condition is intramuscular benzathine penicillin G.Acute Rheumatic Fever TreatmentThe primary treatment goal for a patient diagnosed with acute rheumatic fever is to suppress the...
268
01:26Coronary Artery Disease IV: Preventive Measures
577
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
577
01:29Venous Thrombosis III: Interprofessional Care
268
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
268
01:30Dysrhythmias V: Evaluating Dysrhythmias
315
Dysrhythmias, also known as arrhythmias, are disturbances in the heart's rhythm that range from benign to life-threatening. A thorough evaluation is crucial for appropriate management and involves a comprehensive medical history, physical examination, and various diagnostic tests.Medical HistorySymptoms: Collect detailed information on palpitations, dizziness, syncope, chest pain, and fatigue. Note their onset, frequency, and triggers.Previous Cardiac Issues: Document any history of heart...
315
01:26Atherosclerosis III: Management
301
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
301